Status
Conditions
Treatments
About
The study is an investigator-initiated, prospective cohort trial. The trial aims to evaluate ReDS Pro System V2.7 and ReDS ICU in patients with heart failure (HF).
Full description
The study is an investigator-initiated, prospective cohort trial. The trial aims to evaluate ReDS Pro System V2.7 and ReDS ICU in patients with heart failure (HF). The overall purposes are:
For the out-patient part, the patients will be recruited from the outpatient clinic at Rigshospitalet. The patient must be at least 18 years, have a history of chronic HF, and already monitored using CardioMEMS and must not fulfill any of the exclusion criteria.
For the ICU part, the patients will be recruited at the ICU department at the Heart Center at Rigshospitalet. The patient must be at least 18 years, intubated, and unconscious or sedated (Glasgow Coma Score <8), and already monitored using Swan-Ganz and arterial catherization and must not fulfill any of the exclusion criteria.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
ICU part:
Out-patient part:
Exclusion criteria
ICU part:
Out-patient part:
25 participants in 2 patient groups
Loading...
Central trial contact
Frederik T Sondergaard, MS; Rasmus P Beeske, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal